NEWS
December 8, 2020
New Iridium launches new class of photocatalysts for Birch reduction
Fort Collins, CO
New Iridium has launched a new set of photocatalysts that decrease the cost and safety risks associated with Birch Reductions. These photocatalysts allow for light-driven Birch Reductions under bench-top conditions; leading to safer scale-up reactions. New Iridium has licensed this set of products with Millipore Sigma.
July 8, 2020
New Iridium receives NSF SBIR grant to accelerate Remdesivir production
Fort Collins, CO
New Iridium receives NSF Small Business Technology Transfer (STTR) grant to accelerate potential COVID-19 drug treatment, Remdesivir. We are using our photocatalytic technology to tackle this global issue and help treat people around the world suffering from COVID-19.
August 22, 2019
Runner Up of BizWest's IQ Award Innovation Challenge
Loveland, CO
New Iridium won 2nd place in the BizWest’s Northern Colorado IQ Awards Innovation Challenge. The IQ Awards recognize innovation among new businesses in the northern CO region.
July 8, 2019
ARPA-E 10th Energy Innovation Summit Aurora, CO
New Iridium attended the 2019 ARPA-E Summit. This summit brings together energy stakeholders, industry professionals and technology experts from around the world to discuss and address America’s energy challenges in new and innovative ways. This year’s event recognizes 10 years of ARPA-E making ideas into reality and sets the stage for the next decade of energy innovation.
April 23, 2019
Colorado State University (CSU) Demo Day
Fort Collins, CO
New Iridium participated in CSU Demo Day which was a premiere event that inspires and enriches the entrepreneurial community of CSU and Northern Colorado. Faculty, staff, and students, as well as alumni, business professionals, and entrepreneurs had the opportunity to engage with researchers and local emerging companies in and around our community.
February 5, 2019
Received Phase 1 Funding - NIH SBIR
Boulder, CO
New Iridium received Phase 1 funding from National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program. NIH SBIR program is a highly competitive program that encourages domestic small businesses to engage in Federal Research/Research and Development that has the potential for commercialization.
September 1, 2018
Meeting with Merck & Co.
Kenilworth, NJ
Dr. Chern-Hooi Lim visited the Photoredox team in Merck & Co.
April 21, 2020
Dr. Harit Vora joins New Iridium
Fort Collins, CO
Harit joins New Iridium as a Principal Scientist. He completed his B Sc. at the University of Pittsburgh, pursued his doctoral education at Colorado State University and conducted his postdoctoral research at The Scripps Research Institute. Dr. Vora provides the company with experience from the pharmaceutical sector ( Roche & Merck) and the biotech arena ( C4 Therapeutics & Casma Therapeutics).
January 20, 2020
Celia Federico joins New Iridium
Fort Collins, CO
Celia joins New Iridium as a Research Scientist. Celia recently graduated with a chemistry degree from The College of New Jersey. Throughout her time as an undergraduate, she also conducted research at Colorado State University, The College of New Jersey, and Los Alamos National Lab
December 2, 2019
Awarded National Science Foundation (NSF) Phase 1 $225,000
New Iridium received $225,000 Phase 1 funding from National Science Foundation (NSF)'s Small Business Innovation Research (SBIR) program.
NSF is proud to support the technology of the future by thinking beyond incremental developments and funding the most creative, impactful ideas across all markets and areas of science and engineering
July 8, 2019
Exclusive Licensing Agreement with University of Colorado
Boulder, CO
New Iridium have executed an Exclusive Licensing Agreement with CU Boulder for the the patent in regards to Compositions and Methods of Promoting Organic Photocatalysis.
March 31 - April 4, 2019
American Chemical Society (ACS) Spring Conference
Orlando, FL
Dr. Chern-Hooi Lim attended and presented at the ACS conference. Topics presented are:
-
Strongly reducing organic dihydrophenazine and phenixazine photoredox catalysts for visible light-driven synthesis of polymers and small molecules
-
Benzimidazoles as Metal-Free and Recyclable Hydrides for CO2 Reduction to Formate
-
C-N Cross-Coupling via Photoexcitation of Nickel-Amine Complexes
February 1, 2019
Destination Startup - University of Colorado
Boulder, CO
New Iridium participated in the Destination Startup program hosted by Venture Partners of CU Boulder. This program is a collaboration among Colorado's leading research universities and federal laboratories, showcasing the best technologies from the region’s innovation ecosystem.
January 4, 2020
Featured on Boulder's Daily Camera for receiving grant from OEDIT
New Iridium was featured on Daily Camera as 1 of 6 Boulder-based startups with ties to the University of Colorado Boulder for all their innovation with $1.5 million in grants from the Colorado Office of Economic Development and International Trade (OEDIT).
October 29, 2019
Webinar: Fundamentals & Applications of Photoredox Catalysts in Organic & Macromolecular Synthesis
Garret Miyake, Professor of Colorado State University and Co-Founder of New Iridium was the keynote speaker to discuss the fundamentals of photoredox catalysts application in organic synthesis. Webinar recording can be found here. This event is sponsored by Merck KGaA and MilliporeSigma.
July 21 - 26, 2019
International Conference on Photochemistry (ICP)
Boulder, CO
Dr. Chern-Hooi Lim participated and presented in the ICP 2019 conference. Topics presented are:
-
Strongly Reducing Organic Photoredox Catalysts for Visible Light-driven Synthesis of Polymers and Small Molecules
-
Visible-light-driven Conversion of CO2 to CH4 with an Organic Sensitizer and an Iron Porphyrin Catalyst
June 12, 2019
Dr. David J Boston joins New Iridium
Fort Collins, CO
Dr. David J. Boston joins New Iridium as a lead scientist. Dr. Boston earned his Ph.D. in Inorganic Chemistry from the University of Texas at Arlington in 2013, where his dissertation topic was “Examining Ruthenium Chromophores for the Photochemical Reduction of CO2 to Methanol”. Dr. Boston holds a B.Sc. in Chemistry from Iowa State University (2006), where his undergraduate research project was in catalysis for asymmetric hydrogen transfer.
March 1, 2019
Established Lab Space in Colorado State University
Fort Collins, CO
Started leasing lab space from CSU.
January 27-31, 2019
Winter Conference on Medicinal & Bioorganic Chemistry (WCMBC)
Steamboat Springs, CO
Dr. Chern-Hooi Lim attended the 14th Winter Conference on Medicinal & Bioorganic Chemistry (WCMBC) conference.
May 1, 2018
Marianne Foo joins New Iridium
Boulder, CO
Marianne Foo joins as a part-time CFO of New Iridium. Ms. Foo has a B.S. in Business Administration (Finance and Accounting) from Drexel University. Ms. Foo is a Senior Consultant for Deloitte Consulting and has over eight years experience with global clients in industries ranging from pharmaceutical to consumer and industrial products.